Trademark Search in Canada

CUREMARK

View On IC.GC.CA

REGISTERED

on 3 May 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

CUREMARK LLC

Suite 528 South800 Westchester AvenueRye Brook, New York 10573

Serial Number

2119362 filed on 28^th Apr 2021

Registration Number

TMA1231016 registered on 3^rd May 2024

Registration expiry Date

28^th Apr 2031

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

CUREMARK

Trademark usage description

pharmaceutical preparations and substances for the diagnosis, treatment and prevention of fungal, hepatological, respiratory, gastrointestinal, digest Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of fungal, hepatological, respiratory, gastrointestinal, digestive, pulmonary, hormonal, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, oncological diseases and disorders; pharmaceutical preparations for the treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and Williams Syndrome; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral diseases and disorders, namely viral skin infections, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), influenza, coronaviruses; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of bacterial diseases and disorders, namely bacterial skin infections, bacterial infections; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of parasitic diseases and disorders, namely parasitic skin infections; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of metabolic diseases and disorders, namely diabetes, Gaucher disease, Menkes; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of endocrine diseases and disorders, namely growth and thyroid disorders; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of nervous system diseases and disorders, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease, dysautonomia, Guilliaine Barre Syndrome; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of neurological diseases and disorders, namely Abulia, Agraphia, Akinetopsia, Alien Hand Syndrome, Allan-Herndon-Dudley Syndrome, Alternating hemiplegia of Childhood, Alzheimer's Disease, Amnesia, Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease), Angelman Syndrome, Anosognosias, Aphasia, Aphantasia, Apraxia, Asomatognosia, Asperger Syndrome, Ataxia, Attention Deficit Hyperactivity Disorder, Auditory Processing Disorder, Autism Spectrum Disorder, Bell's Palsy, Bipolar Disorder, Brain Injury, Brody Myopathy, Canavan Disease, Capgras Delusion, Causalgia, Complex Regional Pain Syndrome, Reflex Sympathetic Dystrophy, Central Pain Syndrome, Cephalic Disorder, Cerebral Atrophy, Cerebral Palsy, Charcot-Marie-Tooth Disease, Chorea, Chronic-Fatigue Syndrome, Chronic Pain, Cockayne Syndrome, Congenital Distal Spinal Muscular Atrophy, Congenital Facial Diplegia, Corticobasal Degeneration, Creutzfeldt- Jakob Disease, Cyclothymic Disorder, Dandy-Walker Syndrome, Dawson Disease, Dejerine-Sottas Disease, Delayed Sleep Phase Disorder/Syndrome, Dementia, Developmental Coordination Disorder, Developmental Dyspraxia, Diabetic Neuropathy, Diffuse Myelinoclastic Sclerosis (Schilder's Disease), Disorders of Consciousness, Distal Hereditary Motor Neuropathy Type V, Down Syndrome, Dravet Syndrome, Duchenne Muscular Dystrophy, Dysarthia, Dysautonomia (Autonomic Dysfunction), Dyscalculia, Dysgraphia, Dyskinesia, Dsylexia, Dystonia, Encephalopathy, Encopresis, Enuresis, Epilepsy, Essential Tremor, Exploding Head Syndrome, Fainting, Familial Spastic Paralysis, Hereditary Spastic Paraplegia, Monomelic Amyotrophy, Hirschsprung's Disease, Holmes-Adie Syndrome, HVTL-1 Associated Myelopathy (Tropical Spastic Paraparesis), Huntington's Disease, Hypoalgesia, Hypoesthesia, Inclusion Body Myositis, Joubert Syndrome, Karak Syndrome, Kerans-Sayre Syndrome, Kleine-Levin Syndrome, Kufor-Rakeb Syndrome, Spinal Muscular Atrophy, Lambert-Eaton Myasthenic Syndrome, Learning Disabilities, Leigh Syndrome, Leukodystrophy, Leukoencephalopathy with Vanishing White Matter, Lewy Body Dementia, Lyme Disease, Parkinson's Disease, Machado-Joseph Disease, Microcephaly, Migraines, Guilliane-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy), Acute motor Axonal Neuropathy, Acute Motor and Sensory Axonal Neuropathy, Pharyngeal-cervical-brachial Variant, Miller Fisher Syndrome, Misophonia, Mitochondrial Myopathy, Mobius Syndrome, Monomelic Amyotrophy, Morvan Syndrome, Motor Skills Disorder, Multifocal Motor Neuropathy, Multiple Sclerosis, Multiple System Atrophy, Muscular Dystrophy, Myalgic Encephalomyelitis (Chronic Fatigue Syndrome), Opsoclonus Myoclonus Syndrome, Myoclonus, Myopathy, Myotonia Congenita, Narcolepsy, Neuromyotonia, Neuronal Migration Disorder, Neuropathy, Neurosis, Non-24-Hour Sleep-Wake Disorder, Non-Verbal Learning Disorder, Olivopontocerebellar Atrophy, Opsoclonus Myoclonus Syndrome, Orthostatic Hypotension, Monomelic Amyotrophy, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection, Pantothenate Kinase-Associated Neurodegeneration, Paresthesia, Paroxysmal Attacks, Periodic Paralyses, Peripheral Neuropathy, Pervaisve Development Disorders, Phantom Limb, Phantom Pain, Pick's Disease, Polyneuropathy, Polymicogyria, Posttraumatic Stress Disorder, Postural Hypotension, Postural Orthostatic Tachycardia Syndrome, Prader-Will Syndrome, Primary Lateral Sclerosis, Prion Diseases, Progressive Supranuclear Palsy, Ramsay Hunt Syndrome, Ramsay Hunt Syndrome Type I, Ramsay-Hunt Syndrome Type II, Rapid Eye Movement Sleep Behavior Disorder, Restless Leg Syndrome, Rett Syndrome, Reye Syndrome, Rythmic Movement Disorder, Chorea (Sydenham's Chorea, Chorea Minor, St Vitus Dance), Sandhoff Disease, Sanfilippo Disease, Sensory Processing Disorder, Shy-Drager Syndrome, Sleep Apnea, Spasticity, Spinal Chord Injury, Spinal and Bulbar Muscular Atrophy (Kennedy's Disease), Spinal Muscular Atrophy, Spinocerebellar Ataxia, Progressive Supranuclear Palsy, Stuttering, Binswanger's Disease, Superficial Siderosis, Tardive Dyskinisia, Thalamocortical Dysrhythmia, Myotonia Congenita (Thomsen Disease), Todd's Paresis, Tourette Syndrome, Traumatic Brain Injury, Tremor, Trichotillomania, Tuberous sclerosis complex, Wallenberg's Syndrome (Lateral Medullary Syndrome), Wernicke's Encephalopathy, Williams Syndrome, Wilson's Disease, Zellweger Syndrome; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of dermatological diseases and disorders, namely acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, bacterial skin infections, dermatitis, skin pigmentation diseases, and psoriasis; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of psychiatric diseases and disorders, namely depression, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorders, obsessive compulsive disorder, body misphorbic disorder, and psychoses; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of infectious diseases and disorders, namely respiratory infections, eye infections; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of behavioral diseases and disorders, namely Oppositional Defiant Disorder, Intermittent Explosive Disorder, Conduct Disorder (Childhood-onset type, Adolescent-onset type, Unspecified Onset), Antisocial Personality Disorder, Pyromania, Kleptomania, Other Specified Disruptive, Impulse Control, and Conduct Disorder, Unspecified Disruptive, Impulse Control, and Conduct Disorder, sleep disorders, insomnia; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of physical and psychological addictive diseases and disorders, namely drug and chemical addictions, caffeine addictions, gambling addictions, eating disorders and additions, nicotine addictions; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of sexual dysfunction; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of immune system related diseases and disorders, namely Addison disease, Celiac, Dermatomostis Graves, Multiple Sclerosis, Lupus; pharmaceutical preparations and substances for the diagnosis, treatment and prevention of pharmaceutical preparations for the treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and Williams Syndrome; antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics, namely disinfectants for medical apparatus and instruments, allpurpose disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes, namely antimicrobial hand-sanitizing preparations, antimicrobials for dermatologic use, antimicrobial handwash; medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; diagnostic biomarkers for in vitro testing for medical use; diagnostic preparations for in vitro testing for medical use; biological preparations made from human blood cells for the treatment of cancer; biological preparations made from human blood cells for use in T-cell immunotherapy; diagnostic preparations for clinical laboratory use; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing, namely medical diagnostic reagents and assays for testing of body fluids, reagents for use in diagnostic tests for medical purposes, reagents for use in testing proteins for medical diagnostic purposes, diagnostic chemical reagents for medical purposes, diagnostic biomarker reagents for medical testing.

Classification kind code

Class [042]
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; pharmaceutical drug development services; medical product development services for others; product research and development in the field of ethical pharmaceuticals and over-the-counter drugs; providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body.

Classification kind code

Class [044]
Medical testing for diagnostic and treatment purposes; information, advisory and consultancy services in the field of medical treatment services; information, advisory and consultancy services in the field of medical care and analysis services; information, advisory and consultancy services in the field of medical testing services; health care consultancy in the fields of public health, health assessments, and medical clinic services; information, advisory and consultancy services in the field of medical clinic services; medical diagnostic consultations provided via phone; medical diagnostic consultations provided via videoconferencing; medical diagnostic consultations provided through online chat functions; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and Williams Syndrome; medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases.

Classification kind code

Mark Details

Serial Number

2119362

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 19^th Oct 2022	Search Recorded
Submitted for opposition 20 on 19^th Oct 2022	Examiner's First Report
Submitted for opposition 135 on 25^th Aug 2022	Amendment to Application
Submitted for opposition 256 on 9^th May 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 1^st Dec 2021	Agent Changed
Submitted for opposition 257 on 8^th Jul 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 7^th Jul 2021	Created
Submitted for opposition 31 on 7^th Jul 2021	Formalized
Submitted for opposition 30 on 28^th Apr 2021	Filed
Submitted for opposition 228 on 28^th Apr 2021	International Registration